Observational Disease Registry of Patients Treated with Systemic Mold-Active Triazoles

Study Overview

This study seeks to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs) ,including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat IFIs.

Study Description

This study seeks to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs) ,including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat IFIs.

Additional Information

Participants will not be paid for their participation.


  • IRB Number: 1608845528
  • Research Study Identifier: TX7511
  • Principal Investigator: Chadi Hage, MD

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176